GSK PLC closed 23.91% below its 52-week high of £18.24, which the company reached on May 16th.

GSK PLC GSK shares advanced 3.35% to £14.02 Monday, on what proved to be an all-around great trading session for the stock ...

The European Commission (EC) has authorised the use of ViiV Healthcare’s Vocabria (cabotegravir long-acting injections) plus ...

Harvey Jones isn't having much fun playing the GSK share price game. The FTSE 100 pharmaceutical stock must work hard to make ...

GSK and the University of Oxford have entered a new research partnership to launch an immuno-prevention programme to explore ...

The new EU compass could support small companies to grow their market share across Europe, assisted by fewer regulatory ...

GSK (GSK) stock in focus as its experimental drug depemokimab undergoes EU review for asthma and nasal polyps. Read more here ...

Fintech major BharatPe’s chief marketing officer Parth Joshi is stepping down from his position to ‘pursue an entrepreneurial ...

GSK will invest up to £50 million in the new project, which could inform future development of cancer vaccines. The ...

GSK plc has announced that new drug applications have been accepted for review by the China National Medical Products ...

Sir Jonathan joins Vanessa Bowcock who was appointed as a Senior Adviser at 5654 in late 2024. Vanessa brings nearly 20-years' experience working for the Labour Party in both Government and Opposition ...

Eight new members have been appointed to the Council that advises the Prime Minister and Cabinet on science and technology.